IL-6-trans-signalling increases rapid-eye-movement sleep in rats

European Journal of Pharmacology

Volumn 613, Issue 1-3, 2009, Pages 141-145

  May, Ulrike ^a   Schiffelholz, Thomas ^a   Baier, Paul Christian ^a   Krueger, James M ^b   Rose John, Stefan ^a   Scheller, Jürgen ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

(Rat); Cytokine; Hyper IL 6; IL 6 trans signalling; Sleep

Indexed keywords

CYTOKINE; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DARK ADAPTATION; EXPERIMENTAL RAT; LIGHT DARK CYCLE; MALE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; RAT; REM SLEEP; SIGNAL TRANSDUCTION; SLEEP WAKING CYCLE; SPRAGUE DAWLEY RAT; WAKEFULNESS;

ANIMALS; BEHAVIOR, ANIMAL; BIOMIMETICS; BRAIN; ELECTROENCEPHALOGRAPHY; HUMANS; INTERLEUKIN-6; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SLEEP, REM; WAKEFULNESS;

EID: 65749090415     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.04.023     Document Type: Article

References (41)

1. Balschun D., Wetzel W., Del Rey A., Pitossi F., Schneider H., Zuschratter W., and Besedovsky H.O. Interleukin-6: a cytokine to forget. Faseb J. 18 (2004) 1788-1790
2. Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur. J. Pharmacol. 500 (2004) 399-411
3. De Cock V.C., Vidailhet M., and Arnulf I. Sleep disturbances in patients with parkinsonism. Nat. Clin. Pract. Neurol. 4 (2008) 254-266
4. Dimitrov S., Lange T., Benedict C., Scheller J., Rose-John S., Jones S., and Born J. Sleep enhances il-6 trans-signaling in humans. Faseb J. 20 (2006) 2174-2176
5. Edwards D., Handsley M., and Pennington C. The ADAM metalloproteinases. Mol. Aspects Med. 29 (2008) 258-289
6. Epstein A.M., Fitzsimons J.T., and Rolls B.J. Drinking induced by injection of angiotensin into the brain of the rat. J. Physiol. 210 (1970) 457-474
7. Fang J., Sanborn C.K., Renegar K.B., Majde J.A., and Krueger J.M. Influenza viral infections enhance sleep in mice. Proc. Soc. Exp. Biol. Med. 210 (1995) 242-252
8. Fischer M., Goldschmitt J., Peschel C., Brakenhoff J.P., Kallen K.J., Wollmer A., Grotzinger J., and Rose-John S. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat. Biotechnol. 15 (1997) 142-145
9. Franken P., Malafosse A., and Tafti M. Genetic variation in EEG activity during sleep in inbred mice. Am. J. Physiol. 275 (1998) R1127-1137
10. Gadient R.A., and Otten U. Differential expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat hypothalamus. Neurosci. Lett. 153 (1993) 13-16
11. Helwig B.G., Craig R.A., Fels R.J., Blecha F., and Kenney M.J. Central nervous system administration of interleukin-6 produces splenic sympathoexcitation. Auton. Neurosci.: Basic Clin. 141 (2008) 104-111
12. Hogan D., Morrow J.D., Smith E.M., and Opp M.R. Interleukin-6 alters sleep of rats. J. Neuroimmunol. 137 (2003) 59-66
13. Klein B., Zhang X.G., Lu Z.Y., and Bataille R. Interleukin-6 in human multiple myeloma. Blood 85 (1995) 863-872
14. Krueger J.M., Rector D.M., and Churchill L. Sleep and cytokines. Sleep Med. Clin. 2 (2007) 161-169
15. März P., Gadient R.A., and Otten U. Expression of interleukin-6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: modulation by tumor necrosis factor alpha (TNF-alpha). Brain Res. 706 (1996) 71-79
16. März P., Heese K., Hock C., Golombowski S., Müller-Spahn F., Rose-John S., and Otten U. Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered cerebrospinal fluid of Alzheimer's disease patients. Neurosci. Lett. 239 (1997) 29-32
17. März P., Herget T., Lang E., Otten U., and Rose-John S. Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation. Eur. J. Neurosci. 9 (1997) 2765-2773
18. März P., Cheng J.-C., Gadient R.A., Patterson P., Stoyan T., Otten U., and Rose-John S. Sympathetic neurons can produce and respond to interleukin-6. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 3251-3256
19. März P., Heese K., Dimitriades-Schmutz B., Rose-John S., and Otten U. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression. Glia 26 (1999) 191-200
20. März P., Otten U., and Rose-John S. Neural activities of IL-6-type cytokines often depend on soluble cytokine receptors. Eur. J. Neurosci. 11 (1999) 2995-3004
21. Matarese G., and La Cava A. The intricate interface between immune system and metabolism. Trends Immunol. 25 (2004) 193-200
22. Montero-Julian F.A. The soluble IL-6 receptors: serum levels and biological function. Cell Mol. Biol. (Noisy-le-Gd.) 47 (2001) 583-597
23. Moro M.A., Hurtado O., Cardenas A., Romera C., Madrigal J.L., Fernandez-Tome P., Leza J.C., Lorenzo P., and Lizasoain I. Expression and function of tumour necrosis factor-alpha-converting enzyme in the central nervous system. Neurosignals 12 (2003) 53-58
24. Morrow J.D., and Opp M.R. Sleep-wake behavior and responses of interleukin-6-deficient mice to sleep deprivation. Brain Behav. Immun. 19 (2005) 28-39
25. Neckelmann D., and Ursin R. Sleep stages and EEG power spectrum in relation to acoustcal stimulus arousal threshold in the rat. Sleep 16 (1993) 467-477
26. Opp M., Obal F.J., Cady A.B., Johannsen L., and Krueger J.M. Interleukin-6 is pyrogenic but not somnogenic. Physiol. Behav. 45 (1989) 1069-1072
27. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (2005), Academic Press, San Diego, CA
28. Redwine L., Hauger R.L., Gillin J.C., and Irwin M. Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J. Clin. Endocrinol. Metab. 85 (2000) 3597-3603
29. Rose-John S., and Neurath M. IL-6 trans-signaling: the heat is on. Immunity 20 (2004) 2-4
30. Sawada M., Itoh Y., Suzumura A., and Marunouchi T. Expression of cytokine receptors in cultured neuronal and glial cells. Neurosci. Lett. 160 (1993) 131-134
31. Schäfer K.H., Mestres P., März P., and Rose-John S. The IL-6/sIL-6R fusion protein promotes neurite outgrowth and neuronal survival in cultured enteric neurons. J. Interferon Cytokine Res. 19 (1999) 527-532
32. Scheller J., Grötzinger J., and Rose-John S. Updating Interleukin-6 classic- and trans-signaling. Signal Transduct. 6 (2006) 240-259
33. Schöbitz B., Pezeshki G., Pohl T., Hemmann U., Heinrich P.C., Holsboer F., and Reul J.M. Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. Faseb J. 9 (1995) 659-664
34. Späth-Schwalbe E., Hansen K., Schmidt F., Schrezenmeier H., Marshall L., Burger K., Fehm H.L., and Born J. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J. Clin. Endocrinol. Metab. 83 (1998) 1573-1579
35. Toth L.A., and Krueger J.M. Alteration of sleep in rabbits by Staphylococcus aureus infection. Infect. Immun. 56 (1988) 1785-1791
36. Vallieres L., Lacroix S., and Rivest S. Influence of interleukin-6 on neural activity and transcription of the gene encoding corticotrophin-releasing factor in the rat brain: an effect depending upon the route of administration. Eur. J. Neurosci. 9 (1997) 1461-1472
37. Van Wagoner N.J., Oh J.W., Repovic P., and Benveniste E.N. Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. J. Neurosci. 19 (1999) 5236-5244
38. Vgontzas A.N., Zoumakis M., Bixler E.O., Lin H.M., Prolo P., Vela-Bueno A., Kales A., and Chrousos G.P. Impaired night time sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J. Clin. Endocrinol. Metab. 88 (2003) 2087-2095
39. Vgontzas A.N., Zoumakis E., Bixler E.O., Lin H.M., Follett H., Kales A., and Chrousos G.P. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J. Clin. Endocrinol. Metab. 89 (2004) 2119-2126
40. Watanabe D., Yoshimura R., Khalil M., Yoshida K., Kishimoto T., Taga T., and Kiyama H. Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain. Eur. J. Neursci. 8 (1996) 1630-1640
41. Yan H.Q., Banos M.A., Herregodts P., Hooghe R., and Hooghe Peters E.L. Expression of interleukin (IL)-1 beta, IL-6 and their respective receptors in the normal rat brain and after injury. Eur. J. Immunol. 22 (1992) 2963-2971